Drug Chatter -- Tracking biopharma stock chatter

Profile for Cytokinetics, Incorporated (CYTK)

« Back to company index

CYTK Chatter Timeline

Stock Ticker for CYTK

Most Active Tweeters for CYTK

UserTweets
@storminvestor 5
@CFinancialNews 4
@pharma_sector 4
@intercooleronli 4
@SPNewsAnalysis 4

Recent Tweets for CYTK

SleekMoneycom @SleekMoneycom
Cytokinetics, Incorporated $CYTK Insider Sells $147,912.60 in Stock https://t.co/zOpWBBBbNI
September 25th 2017, 12:09am
CFinancialNews @CFinancialNews
Cytokinetics, Incorporated $CYTK Given Average Recommendation of “Buy” by Analysts https://t.co/9yUSeYjrO3
September 24th 2017, 2:09pm
intercooleronli @intercooleronli
Cytokinetics, Incorporated $CYTK Given Average Recommendation of “Buy” by Analysts https://t.co/54iYJ94Fbc
September 24th 2017, 2:09pm
SPNewsAnalysis @SPNewsAnalysis
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cytokinetics, $CYTK Share Price https://t.co/ETtDMIH19l
September 24th 2017, 10:09am
storminvestor @storminvestor
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cytokinetics, $CYTK Share Price https://t.co/hhV1RxO9AY
September 24th 2017, 10:09am
dakotafinancial @dakotafinancial
Cytokinetics, Incorporated $CYTK Stock Rating Reaffirmed by HC Wainwright https://t.co/136aIPo870
September 24th 2017, 6:09am
dailypoliticaln @dailypoliticaln
HC Wainwright Reaffirms “Buy” Rating for Cytokinetics, Incorporated $CYTK https://t.co/LKiV7tzhUq
September 23rd 2017, 11:09am
WKRBNews @WKRBNews
HC Wainwright Reaffirms “Buy” Rating for Cytokinetics, Incorporated $CYTK https://t.co/blmQufg8se
September 23rd 2017, 11:09am
dailymailtimes @dailymailtimes
HC Wainwright Reaffirms “Buy” Rating for Cytokinetics, Incorporated $CYTK https://t.co/omZ03dn2qa
September 23rd 2017, 11:09am
midetimes @midetimes
HC Wainwright Reaffirms “Buy” Rating for Cytokinetics, Incorporated $CYTK https://t.co/tsd2fpEmek
September 23rd 2017, 11:09am
WatchlistN @WatchlistN
Cytokinetics, Incorporated $CYTK Rating Reiterated by HC Wainwright https://t.co/fL73asdkIS
September 22nd 2017, 5:09am
ZolmaxNews @ZolmaxNews
Citigroup Inc. Acquires 71,811 Shares of Cytokinetics, Incorporated $CYTK https://t.co/cUQ9wsRpLu
September 21st 2017, 11:09am
TheMarketsDaily @TheMarketsDaily
Cantor Fitzgerald Reaffirms “Buy” Rating for Cytokinetics, Incorporated $CYTK https://t.co/uCL3bXaVXL
September 21st 2017, 6:09am
storminvestor @storminvestor
Cytokinetics,’s $CYTK “Buy” Rating Reaffirmed at Needham & Company LLC https://t.co/bTyoQaWCxi
September 21st 2017, 1:09am
CFinancialNews @CFinancialNews
Cytokinetics, Incorporated $CYTK Stock Rating Reaffirmed by HC Wainwright https://t.co/jZHWvaCAuo
September 20th 2017, 5:09pm
intercooleronli @intercooleronli
Cytokinetics, Incorporated $CYTK Stock Rating Reaffirmed by HC Wainwright https://t.co/9GbFfpTh6x
September 20th 2017, 5:09pm
stocknewsdotcom @stocknewsdotcom
$CYTK H.C. Wainwright & Co. reiterates Buy rating, $26 PT https://t.co/374wsfetTy
September 20th 2017, 2:09pm
emq_news @emq_news
Cantor Fitzgerald Reiterates Buy Rating for Cytokinetics, Incorporated $CYTK https://t.co/WKLUoj44Iq
September 20th 2017, 5:09am
ZolmaxNews @ZolmaxNews
Needham & Company LLC Reaffirms Buy Rating for Cytokinetics, Incorporated $CYTK https://t.co/IVMlhc08Qh
September 20th 2017, 5:09am
TickerReport @TickerReport
Cantor Fitzgerald Reiterates Buy Rating for Cytokinetics, Incorporated $CYTK https://t.co/UJLD6v0S4e
September 20th 2017, 5:09am
TickerReport @TickerReport
Cantor Fitzgerald Reiterates Buy Rating for Cytokinetics, Incorporated $CYTK https://t.co/CfFOBhDmoc
September 20th 2017, 5:09am
confcalltran @confcalltran
Cytokinetics Announces Dosing Of First Patient In Japan In Galactic-Hf, Phase 3 Clinical Trial https://t.co/3pKGsm1EWI $CYTK
September 19th 2017, 5:09pm
QLFilings @QLFilings
$CYTK filed Form 8-K with the SEC. Most mentioned words: cytokinetics, mecarbil, omecamtiv, clinical, heart
September 19th 2017, 5:09pm
pharma_sector @pharma_sector
#Cytokinetics Announces Dosing Of First Patient In Japan In GALACTIC-HF, Phase III Clinical... Read more: https://t.co/pmnteCQib0 $CYTK
September 19th 2017, 10:09am
biotech_sector @biotech_sector
#Cytokinetics Announces Dosing Of First Patient In Japan In GALACTIC-HF, Phase III Clinical... Read more: https://t.co/GJ2nbRoDmA $CYTK
September 19th 2017, 10:09am
StocksThatGo @StocksThatGo
ALERT: NEWS $CYTK Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in
September 19th 2017, 9:09am
IRAMarketReport @IRAMarketReport
Cytokinetics, Incorporated $CYTK Given “Buy” Rating at Cantor Fitzgerald https://t.co/MlY82es9BZ
September 19th 2017, 8:09am
chaffeybreeze @chaffeybreeze
Cytokinetics, Incorporated $CYTK Given “Buy” Rating at Cantor Fitzgerald https://t.co/8OelBp1aU3
September 19th 2017, 8:09am
JSTOCKBROKERS @JSTOCKBROKERS
RT @odibro: $CYTK Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Fail…
September 19th 2017, 8:09am
biotech_sector @biotech_sector
BRIEF-#Cytokinetics announces dosing of first patient in Japan in phase 3 clinical trial of... Read more: https://t.co/Iz81xPeVrP $CYTK
September 19th 2017, 8:09am
pharma_sector @pharma_sector
BRIEF-#Cytokinetics announces dosing of first patient in Japan in phase 3 clinical trial of... Read more: https://t.co/MNnvo4xGtW $CYTK
September 19th 2017, 8:09am
StockNewsWires @StockNewsWires
$CYTK: Cytokinetics Announces Dosing of First Patient in Japan in …: https://t.co/IPfAm2fzUc
September 19th 2017, 7:09am
stockboardinc @stockboardinc
$CYTK Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Om... - https://t.co/uzONWfMhjv
September 19th 2017, 7:09am
odibro @odibro
$CYTK Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
September 19th 2017, 7:09am
VisualStockRSRC @VisualStockRSRC
$CYTK - Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of https://t.co/B72JypQN1s
September 19th 2017, 7:09am
shaneblackmon @shaneblackmon
$CYTK doses first patient in Japan in GALACTIC-HF, $10m milestone received
September 19th 2017, 7:09am
TheTradeXchange @TheTradeXchange
$CYTK- Announces Dosing of 1ST Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
September 19th 2017, 7:09am
Allstocknews @Allstocknews
$CYTK Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omeca From our Stock News Alerts App
September 19th 2017, 7:09am
GNWLive @GNWLive
Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv $CYTK https://t.co/KAyjej0xGD
September 19th 2017, 7:09am
TheMarketsDaily @TheMarketsDaily
Needham & Company LLC Reiterates Buy Rating for Cytokinetics, Incorporated $CYTK https://t.co/P8Qs7WeWoL
September 19th 2017, 1:09am
bankerstribune @bankerstribune
Cantor Fitzgerald reiterated Cytokinetics, $CYTK at Buy. 5yr DCF implies it's worth a look https://t.co/5FfkDHoINK
September 18th 2017, 7:09pm
wosaikeneriki @wosaikeneriki
Ecor1 Capital Has Lowered Its Cytokinetics $CYTK Holding by $9.50 Million as Shares Rose ...
September 18th 2017, 3:09pm
StockSpotter @StockSpotter
$CYTK up 2.1% to 14.45 since our bullish alert yesterday after the close #stocks #trading https://t.co/UUDMwHxJX5
September 18th 2017, 10:09am
stocknewsdotcom @stocknewsdotcom
$CYTK Cantor Fitzgerald reiterates Buy rating, $21 PT https://t.co/LNgqlgDxZ0
September 18th 2017, 10:09am
storminvestor @storminvestor
324,693 Shares in Cytokinetics, Incorporated $CYTK Acquired by Laurion Capital Management LP https://t.co/91HFshPa1l
September 18th 2017, 9:09am
SPNewsAnalysis @SPNewsAnalysis
324,693 Shares in Cytokinetics, Incorporated $CYTK Acquired by Laurion Capital Management LP https://t.co/ONIisA8Wom
September 18th 2017, 9:09am
intercooleronli @intercooleronli
Cytokinetics, Incorporated $CYTK Given Buy Rating at Cantor Fitzgerald https://t.co/GRYf4HlMk8
September 18th 2017, 9:09am
CFinancialNews @CFinancialNews
Cytokinetics, Incorporated $CYTK Given Buy Rating at Cantor Fitzgerald https://t.co/WFSlJNulBq
September 18th 2017, 9:09am
dakotafinancial @dakotafinancial
Cytokinetics,’s $CYTK Buy Rating Reiterated at Cantor Fitzgerald https://t.co/GwaZj8HS87
September 18th 2017, 9:09am
RatingsNetwork @RatingsNetwork
Cytokinetics, Incorporated's buy rating reiterated at Cantor Fitzgerald. $21.00 PT. https://t.co/eV63neRMEu $CYTK #CYTK
September 18th 2017, 9:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.